Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · Real-Time Price · USD
5.99
+0.77 (14.75%)
At close: Jun 6, 2025, 4:00 PM
5.70
-0.29 (-4.84%)
After-hours: Jun 6, 2025, 5:06 PM EDT
Astria Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
78
Market Cap
338.04M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
ATXS News
- 1 day ago - Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Annual Congress - Business Wire
- 3 days ago - Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 10 days ago - Astria Therapeutics to Present at Upcoming Jefferies Global Healthcare Conference - Business Wire
- 15 days ago - Astria Therapeutics to Present at Upcoming C1 Inhibitor Deficiency and Angioedema Workshop - Business Wire
- 16 days ago - Astria Therapeutics to Present at Upcoming Eastern Allergy Conference - Business Wire
- 24 days ago - Astria Therapeutics Reports First Quarter 2025 Financial Results and Provides a Corporate Update - Business Wire
- 5 weeks ago - Astria Therapeutics Announces Publication of Navenibart Phase 1a Healthy Subject Results in the Annals of Allergy, Asthma & Immunology - Business Wire
- 5 weeks ago - Astria Therapeutics to Present at Upcoming Citizens Life Sciences Conference - Business Wire